May 2023

ImmunoGen

ImmunoGen

Lead Manager (Follow-On)

Canaccord Genuity Acts as Lead Manager to ImmunoGen on its Follow-On Offering

More Like This

US$17m

April 2025

Lucid Diagnostics

Sole Bookrunner (Follow-On Offering)
US$15m

March 2025

Lucid Diagnostics

Sole Placement Agent (Registered Direct Offering)
February 2025

Exploristics

Exclusive Financial Advisor to Exploristics on its Acquisition by MMS Holdings

View all Healthcare transactions